Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan

International Journal of Cancer

Volumn 67, Issue 5, 1996, Pages 620-625

  Wang, Li Yu ^a,b   Hatch, Maureen ^c   Chen, Chien Jen ^a   Levin, Bruce ^b   You, San Lin ^a   Sheng Nan, L U ^d   Mei Huei, W U ^b   Wei Pin, W U ^e   Wang, Lian Wen ^b   Wang, Qiao ^b   Huang, Guan Tarn ^f   Yang, Pei Ming ^f   Lee, Hsuan Shu ^f   Santella, Regina M ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e Taiwan Provincial Penghu Hospital   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; DRUG METABOLITE; HEPATITIS B SURFACE ANTIGEN;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENVIRONMENT; FEMALE; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TAIWAN;

AFLATOXINS; ALCOHOL DRINKING; CARCINOMA, HEPATOCELLULAR; ENVIRONMENTAL EXPOSURE; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER NEOPLASMS; MALE; RISK FACTORS; SERUM ALBUMIN; SMOKING; TAIWAN;

EID: 9544236289     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960904)67:5<620::AID-IJC5>3.0.CO;2-W     Document Type: Article

References (25)

1. ALLEN, S.J., WILD, C.P., RILEY, E.M., MONTESANO, R., BENNETT, S., WHITTLE, H.C., HALL, A.J. and GREENWOOD, B.M., Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children. Trans. roy. Soc. Trop. Med. Hyg., 58, 426-430 (1992).
2. CHEN, C.J., LIANG, K.Y., CHANG, A.S., CHANG, Y.C., LU, S.N., LIAW, Y.F., CHANG, W.Y., SHEEN, M.C. and LIN, T.M., Effects of hepatitis B virus, alcohol drinking, cigarette smoking, and familial tendency on hepatocellular carcinoma. Hepatology, 13, 398-406 (1991).
3. CHEN, C.J. and 14 OTHERS, Community-based hepatocellular carcinoma screening in seven townships in Taiwan. J. Formos. med. Assoc., (1996a) (In press).
4. 1-albumin adducts level and risk of hepatocellular carcinoma. Hepatology, (1996b) (In press).
5. 1-DNA adducts in smeared tumor tissue of hepatocellular carcinoma patients. Hepatology, 16, 1150-1155 (1992).
6. COLOMBO, M., DE FRANCHIS, R., DEL NINNO, E., SANGIOVANNI, A., DE FAZIO, C., TOMMASINI, M., DONATO, M.F., PIVA, A., DI CARLO, V. and DIOGUARDI, N., Hepatocellular carcinoma in Italian patients with cirrhosis. New Engl. J. Med., 325, 675-680 (1991).
7. 1 and hepatitis B virus infection in the induction of liver tumors in ducks. Cancer Res., 50, 2156-2163 (1990).
8. DEPARTMENT OF HEALTH, EXECUTIVE YUAN, REPUBLIC OF CHINA, Department of health: health statistics, 1993, Department of Health, Yuan (1994).
9. DI BISCEGLIE, A.M., Hepatitis C and hepatocellular carcinoma. Semin. Liver Dis., 15, 64-69 (1995).
10. EATON, D.L. and GALLAGHER, E.P., Mechanisms of aflatoxin carcinogenesis. Ann. Rev. Pharmacol. Toxicol., 34, 135-172 (1994).
11. FETTELSON, J., Hepatitis B virus infection and primary hepatocellular carcinoma. Clin. Microbiol. Rev., 5, 275-301 (1992).
12. HATCH, M.C., CHEN, C.J., LEVIN, B., JI, B.T., YANG, G.Y., HSU, S.W., WANG, L.W. and SANTELLA, R.M., Urinary aflatoxin levels, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Int. J. Cancer, 54, 931-934 (1993).
13. IARC, Evaluation of carcinogenic risks to humans. IARC Monographs, 56, 245-395 (1992).
14. LIAW, Y.F., Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology, 22, 1101-1108 (1995).
15. LU, S.N., LIN, T.M., CHEN, C.J., CHEN, J.S., LIAW, Y.F., CHANG, W.Y. and HSU, S.T., A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer, 62, 2051-2055 (1988).
16. MANTEL, N., Chi-square tests with one degree freedom: extension for the Mantel-Haenszel procedure. J. Amer. Stat. Assoc., 58, 690-700 (1963).
17. QIAN, G.S., ROSS, R.K., YU, M.C., YUAN, J.M., GAO, Y.T., HENDERSON, B.E., WOGAN, G.N. and GROOPMAN, J.D., A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai. People's Republic of China. Cancer Epidemiol. Biomarkers Prevent., 3, 3-10 (1994).
18. ROBINSON, W.S., Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma. Ann. Rev. Med., 45, 297-323 (1994).
19. ROSS, R.K., YUAN, J.M., YU, M.C., WOGAN, G.N., QIAN, G.S., TU, J.T., GROOPMAN, J.D., GAO, Y.T. and HENDERSON, B.E., Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946 (1992).
20. SAITO, I. and 12 OTHERS, Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. nat. Acad. Sci. (Wash.), 87, 6547-6549 (1990).
21. SCHLESSELMAN, J.D., Case-control study: design, conduct, analysis, Oxford University Press, New York (1982).
22. SELL, S., HUNT, J.M., DUNSFORD, H.A. and CHISARI, F.V., Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice. Cancer Res., 51, 1278-1285 (1991).
23. SKIPPER, P.L. and TANNENBAUM, S.R., Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis, 11, 507-518 (1990).
24. WILD, C.P., JIANG, Y.Z., SABBIONI, G., CHAPOT, B. and MONTESANO, R., Evaluation of methods for quantitation of aflatoxin-albumin and their application to human exposure assessment. Cancer Res., 50, 245-251 (1990).
25. YU, M.W. and CHEN, C.J., Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit. Rev. Oncol. Hematol., 17, 71-91 (1994).